trending Market Intelligence /marketintelligence/en/news-insights/trending/eg1hxmvgyvuf2gjzbleuwg2 content esgSubNav
In This List

Anika Therapeutics appoints independent director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Anika Therapeutics appoints independent director

Anika Therapeutics Inc. appointed venture-backed biotech Keratin Biosciences Inc.'s president and CEO Cheryl Blanchard as an independent director.

Blanchard is also serving on the boards of SeaSpine Holdings Corp., CeramTec GmbH, Elute Inc. and Bio2 Technologies Inc.

Anika said Blanchard's appointment expanded the board to seven directors, the company said in a Sept. 5 news release, adding that it is looking to appoint an additional director in the coming months.